|
|
|
Volumn 47, Issue 2, 1999, Pages 188-191
|
|
Allogeneic bone marrow transplantation in multiple myeloma
|
|
Author keywords
Allogeneic transplantation; Donor lymphocyte transfusions; Multiple myeloma
|
|
Indexed keywords
BETA 2 MICROGLOBULIN;
BUSULFAN;
CD34 ANTIGEN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
ETOPOSIDE;
IMMUNOGLOBULIN;
INTERFERON;
LOMUSTINE;
MELPHALAN;
ALLOGENIC BONE MARROW TRANSPLANTATION;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER REGRESSION;
DRUG MEGADOSE;
HUMAN;
LYMPHOCYTE TRANSFUSION;
MORTALITY;
MULTIPLE MYELOMA;
PROGNOSIS;
RECURRENCE RISK;
SURVIVAL RATE;
WHOLE BODY RADIATION;
BONE MARROW TRANSPLANTATION;
DISEASE-FREE SURVIVAL;
HUMANS;
MULTIPLE MYELOMA;
REMISSION INDUCTION;
SURVIVAL RATE;
TRANSPLANTATION CONDITIONING;
TRANSPLANTATION, AUTOLOGOUS;
TRANSPLANTATION, HOMOLOGOUS;
|
|
EID: 0032989693
PISSN: 03698114
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (9)
|
|
References (18)
|
